Northwire Canada EditionSunday, July 12, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
M&A / Property

Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada's Leading Medical Cannabis Business By Revenue

WEED · Price

Executive Summary

  • Canopy Growth completed the acquisition of 100% of MTL Cannabis, issuing ~41.2 million Canopy shares and paying approximately C$18.5 million cash to MTL shareholders.
  • The deal creates Canada’s leading medical‑cannabis platform, adds high‑quality flower capacity, expands Québec presence, and is expected to generate ≈C$10 million of run‑rate synergies within 18 months and support a path to positive adjusted EBITDA by FY2027.
  • Key MTL executives (including COO Mike Perron and co‑founders Richard & Michel Clément) join Canopy’s leadership team, strengthening operational depth and integration capabilities.

Key Details

  • Consideration: Each MTL share exchanged for 0.32 Canopy common share + C$0.144 cash.
  • Shares Issued: ~41.2 million Canopy shares to MTL shareholders; additional 2,956,391 shares issued to former MC shareholders (subject to an 18‑month transfer restriction).
  • Cash Paid: Approximately C$18.5 million paid to Odyssey Trust Company in trust for MTL shareholders.
  • De‑listing: MTL shares expected to be de‑listed from the Canadian Securities Exchange around 2026‑03‑16.
  • Leadership Additions:
  • Mike Perron – Chief Operating Officer (formerly CEO of MTL)
  • Richard Clément & Michel Clément – Strategic Advisors
  • Additional senior staff listed in release (e.g., Chrissy McHardy, Andrew Bevan).
  • Strategic Benefits:
  • Strengthens Canopy’s medical‑cannabis market‑share leadership in Canada.
  • Expands high‑quality flower supply for Canadian and international (including European) markets.
  • Deepens Québec footprint via MTL cultivation facilities and product portfolio.
  • Adds profitable, cash‑generating operations to accelerate margin improvement and EBITDA growth.
  • Synergies: Anticipated run‑rate synergies of ~C$10 million within 18 months post‑integration.
  • Advisors & Counsel:
  • Canaccord Genuity – exclusive financial advisor to Canopy.
  • Cassels Brock & Blackwell LLP / Paul Hastings LLP – legal counsel to Canopy.
  • Haywood Securities – exclusive financial advisor to MTL’s special committee (provided fairness opinion).
  • Farris LLP – legal counsel to MTL.

Notable Quotes

  • “The acquisition of MTL is a defining step forward in strengthening Canopy Growth’s core Canadian business and advancing our path toward sustainable profitability.” – Luc Mongeau, CEO, Canopy Growth.
  • “We’re proud to join Canopy Growth and begin this next phase as one team.” – Richard Clément, Co‑Founder & former Chief Cultivation Officer, MTL Cannabis.

All amounts are expressed in Canadian dollars.

Read the original news release →

More from CANOPY GROWTH CORPORATION J